These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9721434)

  • 1. Humanized monoclonals and other biological initiatives.
    Halloran PF; Prommool S
    Clin Biochem; 1998 Jul; 31(5):353-7. PubMed ID: 9721434
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplant Proc; 1999; 31(1-2):1244. PubMed ID: 10083555
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade.
    Wekerle T; Sayegh MH; Chandraker A; Swenson KG; Zhao Y; Sykes M
    Transplant Proc; 1999; 31(1-2):680. PubMed ID: 10083292
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
    Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
    Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
    Onodera K; Chandraker A; Kato H; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1999; 31(1-2):876-7. PubMed ID: 10083384
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
    Lee YH; Miki T; Kuddus R; Tandin A; Goller AL; Subbotin V; Fung JJ; Peach R; Valdivia LA; Rao AS
    Transplant Proc; 2000 Aug; 32(5):1032-3. PubMed ID: 10936336
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.
    Adams AB; Shirasugi N; Durham MM; Strobert E; Anderson D; Rees P; Cowan S; Xu H; Blinder Y; Cheung M; Hollenbaugh D; Kenyon NS; Pearson TC; Larsen CP
    Diabetes; 2002 Feb; 51(2):265-70. PubMed ID: 11812731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking T-cell costimulation to prevent transplant rejection.
    Zheng XG; Turka LA
    Transplant Proc; 1998 Aug; 30(5):2146-9. PubMed ID: 9723421
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model.
    Graser E; Risch K; Linsley PS; Hancock WW; Müller A; Brock J; Reinke P; Kupiec-Weglinski JW; Volk HD; Lehmann M
    Transplant Proc; 1997; 29(1-2):1307-9. PubMed ID: 9123319
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
    Rastellini C; Salam A; Kuddus R; Aitouche A; Subbotin V; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1242-3. PubMed ID: 10083554
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
    Rehman A; Tu Y; Flye MW
    Transplant Proc; 1996 Apr; 28(2):660-1. PubMed ID: 8623331
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of transplant tolerance induction using costimulatory blockade.
    Wekerle T; Kurtz J; Bigenzahn S; Takeuchi Y; Sykes M
    Curr Opin Immunol; 2002 Oct; 14(5):592-600. PubMed ID: 12183158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2.
    Arima T; Rehman A; Flye MW
    Transplant Proc; 1997; 29(1-2):1305-6. PubMed ID: 9123318
    [No Abstract]   [Full Text] [Related]  

  • 16. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1997; 29(1-2):1036-7. PubMed ID: 9123186
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficient myoblast transplantation in mice immunosuppressed with monoclonal antibodies and CTLA4 Ig.
    Guérette B; Wood K; Roy R; Tremblay JP
    Transplant Proc; 1997 Jun; 29(4):1932-4. PubMed ID: 9193460
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM; Sun S; Schechner RS; Tellis VA
    Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment.
    Strehlau J; Maslinski W; Chae D; Pavlakis M; Ehrich JH; Strom TB
    Transplant Proc; 1998 Aug; 30(5):2389-91. PubMed ID: 9723514
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of T-cell-dependent immune responses in monkeys by CTLA4Ig.
    Cabrian KM; Berry KK; Shuford WW; Mittler RS; Rodgers JN; Linsley PS
    Transplant Proc; 1996 Dec; 28(6):3261-2. PubMed ID: 8962265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.